Safety Interim Analyses Of First-Line Systemic Therapy With Atezolizumab Plus Bevacizumab (Atz+Bev) In Patients From Spain With Unresectable Hepatocellular Carcinoma (Hcc): Phase Iiib Atheca
Atezolizumab;Bevacizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Safety Interim Analyses Of First-Line Systemic Therapy With Atezolizumab Plus Bevacizumab (Atz+Bev) In Patients From Spain With Unresectable Hepatocellular Carcinoma (Hcc): Phase Iiib Atheca ### Output: Atezolizumab;Bevacizumab